Executive Insider Trades Show Strong Activity in $CYTK Stock

Andrew Callos, Executive Vice President of $CYTK, recently sold 3,341 shares on March 6, 2025, for approximately $144,565. This transaction was disclosed in a recent SEC filing. The sale accounted for about 4.9% of his holdings in this class of Stock. Following this trade, Callos now holds 64,434 shares of this class of $CYTK Stock.

Recent Insider Trading Activities at $CYTK

In the past six months, insiders at $CYTK have executed trades on the open market 38 times, all of which were sales, with no purchases reported.

Here is a detailed overview of recent insider trading of $CYTK Stock:

• ROBERT I BLUM (President & CEO) recorded 0 purchases and 9 sales, liquidating 80,713 shares for an estimated $3,776,226.
• FADY IBRAHAM MALIK (EVP Research & Development) registered 0 purchases and 21 sales, selling 70,819 shares for around $3,600,480.
• WENDALL WIERENGA conducted 0 purchases and 3 sales, resulting in the sale of 5,936 shares for an estimated $305,785.
• B LYNNE PARSHALL sold 5,000 shares for about $274,600.
• ANDREW CALLOS (EVP, Chief Commercial Officer) participated in 0 purchases and 2 sales, offloading 4,455 shares for roughly $192,333.
• JOHN T HENDERSON sold 1,780 shares valued at approximately $89,747.
• ROBERT ARTHUR HARRINGTON sold 900 shares for about $38,250.

To keep track of insider transactions, visit Quiver Quantitative’s insider trading dashboard.

Institutional Activity Surrounding $CYTK

Recent data reveals that 149 institutional investors have added shares of $CYTK Stock to their portfolios, while 215 have decreased their holdings in the most recent quarter.

Here are notable recent changes by large institutional investors:

• BANK OF AMERICA CORP /DE/ divested 4,610,302 shares (-95.5%) during Q4 2024, realizing an estimated $216,868,606.
• DARWIN GLOBAL MANAGEMENT, LTD. offloaded 4,575,558 shares (-100.0%) in Q3 2024, for an approximate $241,589,462.
• DEEP TRACK CAPITAL, LP increased their stake by adding 1,870,094 shares (+296.9%) in Q4 2024, valued at about $87,969,221.
• PFM HEALTH SCIENCES, LP eliminated 1,757,192 shares (-100.0%) in Q4 2024, translating to an estimated $82,658,311.
• FMR LLC reduced holdings by 1,299,568 shares (-10.7%) in Q4 2024, for an estimated $61,131,678.
• CAPITAL INTERNATIONAL INVESTORS increased their portfolio by acquiring 1,096,164 shares (+inf%) in Q4 2024, valued at around $51,563,554.
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. grew its position by adding 1,062,136 shares (+11.0%) in Q4 2024 for a total of approximately $49,962,877.

For insights into hedge fund activities, visit Quiver Quantitative’s institutional holdings dashboard.

This article is not financial advice. For further details, see Quiver Quantitative’s disclaimers.

This article originally appeared in Quiver News; read the complete story.

The views expressed here are those of the author and do not necessarily reflect those of Nasdaq, Inc.